Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mei Pharma Inc
(NQ:
MEIP
)
3.105
-0.015 (-0.49%)
Streaming Delayed Price
Updated: 12:50 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mei Pharma Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Soluna Holdings Shares Are Trading Sharply Lower; Here Are 38 Stocks Moving Premarket
October 24, 2022
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) rose 70.8% to $0.41 in pre-market trading. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
October 21, 2022
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Why Snap Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
October 21, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 40.9% to $0.2160 in pre-market trading. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 10, 2022
Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 10, 2022
We're starting off the trading week with a look at the biggest pre-market stock movers for Monday morning and the news moving them!
Via
InvestorPlace
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Changes to Board of Directors
September 22, 2022
From
MEI Pharma, Inc.
Via
Business Wire
Looking Into MEI Pharma's Return On Capital Employed
September 15, 2022
MEI Pharma (NASDAQ:MEIP) brought in sales totaling $11.41 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 84.1%, resulting in a loss of $16.06 million.
Via
Benzinga
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
September 08, 2022
From
MEI Pharma, Inc.
Via
Business Wire
Earnings Scheduled For September 8, 2022
September 08, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...
Via
Benzinga
Earnings Outlook For MEI Pharma
September 07, 2022
MEI Pharma (NASDAQ:MEIP) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that MEI Pharma will...
Via
Benzinga
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
September 06, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Release 2022 Fiscal Year End Financial Results and Provide Corporate Update on September 8, 2022
September 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
MEI Pharma and Kyowa Kirin Announce Publication in The Lancet Oncology of Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy
July 18, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
July 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
Looking Into MEI Pharma's Return On Capital Employed
June 23, 2022
According to Benzinga Pro data, during Q3, MEI Pharma (NASDAQ:MEIP) posted sales of $9.69 million. Earnings were up 28.22%, but MEI Pharma still reported an overall loss of $8.72 million.
Via
Benzinga
MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer
June 22, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin Report Clinical Data on Zandelisib at European Hematology Association 2022 Hybrid Congress
June 10, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022
June 04, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
18 Stocks Moving in Wednesday's Pre-Market Session
June 01, 2022
Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.
Via
Benzinga
MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation at the American Society of Clinical Oncology Annual Meeting 2022
May 26, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights
May 23, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI ALERT: Bragar Eagel & Squire, P.C. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm
May 18, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm
May 17, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors
May 17, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
May 17, 2022
On Tuesday, 123 stocks made new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.